Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer
PDB DOI: 10.2210/pdb6usx/pdb
Classification: HYDROLASE/INHIBITOR Organism(s): Salmonella Enterica
Deposited: 2019-10-28 Deposition Author(s): Smith, D.J. , Vigers, G.P.
Method: X-RAY DIFFRACTION Resolution: 2.27 Å
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer
Primary Citation of Related Structures: 6USX
Proteins | ||||
---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Sequence |
GTPase KRas | A | 170 | Salmonella Enterica | GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK |
GTPase KRas | B | 170 | Salmonella Enterica | GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK |
Method: X-RAY DIFFRACTION
Deposited Date: 2019-10-28 Deposition Author(s): Smith, D.J. , Vigers, G.P.